The US-based company's latest funding round has been led by private equity giant L Catterton - which itself is backed by ...

Jefferies raises S&P 500 2025 year-end target to 5,600. Explore sector strategies, economic trends & stock valuation insights.

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...